SXTC

distress 4/10 · elevated risk

$0.37-82%today-100% from 52w high

sxtchina.com56 employeesFounded 2005Taizhou, ChinaDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$28M

Runway

7.0 yrs

Shares 1y

Price & events

-97.3% over 6M

CatalystRating changeDilutionFinancingdashed = today

-81.7%

-85.6%

-85.1%

-82.5%

-97.1%

-99.9%

-99.8%

-100.0%

All

Overview

Market Cap: $354.68K
Enterprise Value: $-27.18M
Volume: 29.86M
52 Week Range: $0.37 – $300
Total Shares: 958.08K
Float Shares: 31.94M
Short %: 0.14%
% Held by Insiders: 109.48%
% Held by Institutions: 0.24%
RVOL: 15.35x
Beta: 1.82

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 958,077 · 3 offerings/1y · 0 PIPEs

2026-07-07F-3shelf_registration
2026-06-01424B5offering
2026-04-09424B5offering
2026-01-12424B5offering
2025-11-14EFFECTshelf_effective
2025-11-10F-3shelf_registration
2025-05-19424B5offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified